跳至主要内容
临床试验/ACTRN12622000693729
ACTRN12622000693729尚未招募未知

Investigation of the effect and cost-effectiveness of nutrition education facilitated through an mHealth program on depressive symptoms in adults.

Deakin University0 个研究点目标入组 672 人开始时间: 2022年5月13日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
672

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Community-dwelling adults (age 18-65)
  • Depressive symptoms of at least mild severity (PHQ-8 greater than or equal to 5)
  • Access to internet and a smartphone or tablet
  • Ability to understand study materials and directions in English
  • Ability to download the mobile application from a respective app store
  • Ability to enter login details provided to access the mobile application
  • Agree not to enrol in another interventional clinical research trial while part of the study

排除标准

  • Currently following a Mediterranean diet (greater than or equal to 11 on MEDAS at baseline) (Downer et al., 2016)
  • Individuals who are pregnant or breastfeeding, or who are intending to become pregnant
  • Individuals prescribed warfarin, heparin and other anti-coagulant medications
  • Individuals on immune-suppressing medication
  • Individuals receiving chemotherapy or radiotherapy
  • Individuals with a diagnosis of liver disease
  • Individuals with a diagnosis of kidney disease
  • Individuals with a diagnosed eating disorder
  • Individuals who have received medical advice to avoid vitamin, mineral or fish oil supplementation
  • Individuals who have commenced nutrient supplementation (vitamins, minerals, and/or fish oil) in the last month
  • Underweight (i.e. BMI less than 18.5)
  • Inability to follow Mediterranean diet study recommendations (i.e. currently vegan or paleo-style diet; inability to follow diet for sociocultural or religious reasons)
  • Diagnosed with or commenced new treatment for, anxiety and/or depression, within 1 month prior to baseline. Stable pharmacological or other therapy for more than one-month prior will not be an exclusion criterion.

研究者

相似试验